Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Stopped No participants enrolled for more than two years. No plan to continue study.
Conditions
Interventions
- BIOLOGICAL: Hematopoietic Stem Cell Transplantation
- DRUG: Cyclophosphamide
- DRUG: ATG (rabbit)
- DRUG: Mesna
- DRUG: Methylprednisolone
- DRUG: G-CSF
Sponsor
Northwestern University